K-Ras mutations occur at high frequencies in colon cancer cells, and they result in constitutive activation of signaling pathways downstream of EGFR, including Ras/MAPK and PI3K-Akt pathways. This evidence concerns the gene KRAS and malignant colon neoplasm.